Reconstituting Lyophilized BPC-157: A Laboratory Handling Guide

Lyophilized peptides arrive as a freeze-dried solid — typically a thin film or powder under vacuum in a sealed vial. Before any in vitro or animal-model work can proceed, the powder must be solubilized in an appropriate aqueous diluent. This guide outlines the standard laboratory procedure for reconstituting BPC-157 while preserving peptide integrity.

• Step 1 — Equilibrate to room temperature. Remove the vial from refrigeration and allow it to reach ambient temperature (~20 minutes). Reconstituting a chilled vial can produce condensation on the rubber stopper that interferes with quantitative transfer [1].
• Step 2 — Select diluent and volume. For a 10 mg vial, 2 mL of bacteriostatic water (0.9% benzyl alcohol) yields a 5 mg/mL stock solution. Sterile water for injection is an acceptable alternative when benzyl alcohol is incompatible with downstream assays. BPC-157 is highly water-soluble due to its hydrophilic residue composition [2].
• Step 3 — Slow-stream addition. Tilt the vial and inject the diluent slowly down the inner wall — never directly onto the lyophilized cake. Direct impact can denature peptide and produce foaming, which complicates volumetric recovery [1].
• Step 4 — Gentle dissolution. Swirl the vial gently for 30-60 seconds. Do not shake or vortex; mechanical shear can fragment longer peptides and aerosolize material into the headspace. Allow the solution to sit for 5 minutes; complete dissolution is usually achieved without additional agitation [2].
• Step 5 — Inspect and aliquot. Visually inspect for clarity. The solution should be optically clear and free of particulates. Aliquot into sterile, low-binding polypropylene tubes and store at −20 °C for long-term work or 2-8 °C for use within 30 days [3].

For laboratory researchers preparing BPC-157 solutions, Frontier Peptide Labs’ BPC-157 10 mg vial ships as lyophilized powder with third-party COA documentation, supplied for laboratory research use only.

References

1. Manning MC, et al. Stability of protein pharmaceuticals: an update. Pharm Res. 2010;27(4):544-575. DOI: 10.1007/s11095-009-0045-6
2. Vlieghe P, et al. Synthetic therapeutic peptides: science and market. Drug Discov Today. 2010;15(1-2):40-56. DOI: 10.1016/j.drudis.2009.10.009
3. Sikiric P, et al. Stable gastric pentadecapeptide BPC 157. Curr Pharm Des. 2011;17(16):1612-32. PubMed: 21548867